Literature DB >> 15606655

Contact allergy to isoeugenol and its derivatives: problems with allergen substitution.

S Tanaka1, C Royds, D Buckley, D A Basketter, A Goossens, M Bruze, C Svedman, T Menné, J D Johansen, I R White, J P McFadden.   

Abstract

A total of 2261 (808 male, 1453 female) consecutive patients attending contact dermatitis clinics were patch tested to isoeugenol and its derivatives listed in the EU Inventory of Fragrance Ingredients. Positive reactions were found to isoeugenol in 40, transisoeugenol in 40, isoeugenyl acetate in 19, isoeugenyl benzoate in 4, isoeugenyl phenylacetate in 16, isoeugenyl methyl ether in 6 and benzyl isoeugenyl ether in 2 patients. There was a concomitant reaction to isoeugenol in 36/40 of those positive to transisoeugenol, 13/19 of those to isoeugenyl acetate, 3/4 of those to isoeugenyl benzoate and 15/16 of those to isoeugenyl phenylacetate but in none of those 6 positive to isoeugenyl methyl ether and in neither of those 2 positive to benzyl isoeugenyl ether. Concomitant contact allergy between isoeugenol and its derivatives may occur through chemical cross-reactivity or local skin metabolism of the derivatives. It is more commonly observed with the esters rather than the ethers. Isoeugenyl acetate has been proposed as an alternative to isoeugenol, but there is a high degree of concomitant reactivity with isoeugenol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606655     DOI: 10.1111/j.0105-1873.2004.00446.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

1.  Expression of Cyclooxygenase-2, Nitric Oxide Synthase 2 and Heme Oxygenase-1 mRNA Induced by Bis-Eugenol in RAW264.7 Cells and their Antioxidant Activity Determined Using the Induction Period Method.

Authors:  Yukio Murakami; Akifumi Kawata; Seiichiro Fujisawa
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

Review 2.  Contact allergy to fragrances: current clinical and regulatory trends.

Authors:  W Uter
Journal:  Allergol Select       Date:  2017-08-04

3.  Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds.

Authors:  André S de Oliveira; Poliana A R Gazolla; Ana Flávia C da S Oliveira; Wagner L Pereira; Lívia C de S Viol; Angélica F da S Maia; Edjon G Santos; Ítalo E P da Silva; Tiago A de Oliveira Mendes; Adalberto M da Silva; Roberto S Dias; Cynthia C da Silva; Marcelo D Polêto; Róbson R Teixeira; Sergio O de Paula
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.